Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplemental Table 6 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
  1. Home
  2. Publications
  3. Supplemental Table 6 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial

Supplemental Table 6 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial

Authors:
  • CJCaron A. Jacobson
    Caron A. Jacobson
  • JWJason R. Westin
    Jason R. Westin
  • DMDavid B. Miklos
    David B. Miklos
  • AHAlex F. Herrera
    Alex F. Herrera
  • JRJerome Ritz
    Jerome Ritz
  • SRScott Rodig
    Scott Rodig
  • YAYohei Arihara
    Yohei Arihara
  • SCSubing Cao
    Subing Cao
  • JSJennifer Sun
    Jennifer Sun
  • DMDaqin Mao
    Daqin Mao
  • SASabina Adhikary
    Sabina Adhikary
  • FNFrank Neumann
    Frank Neumann

Open Access
Publisher website
Google Scholar
  • 2 March 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.31442875
Abstract
Serum peak biomarker associations with CRS and NEs in the final analysis
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • HEMATOLOGICAL CANCERS
  • LYMPHOMAS
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • COMBINATION IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.